Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 4500.0
(2.74%)
JPY 4500.0
(2.74%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.29 Billion JPY | -8.07% |
| 2022 | 14.46 Billion JPY | 4.85% |
| 2021 | 13.79 Billion JPY | 26.14% |
| 2020 | 10.93 Billion JPY | -59.22% |
| 2019 | 26.81 Billion JPY | 62.99% |
| 2018 | 16.45 Billion JPY | -6.64% |
| 2017 | 17.62 Billion JPY | 17.73% |
| 2016 | 14.97 Billion JPY | -6.69% |
| 2015 | 16.04 Billion JPY | 30.15% |
| 2014 | 12.32 Billion JPY | -12.7% |
| 2013 | 14.12 Billion JPY | -3.62% |
| 2012 | 14.65 Billion JPY | 23.1% |
| 2011 | 11.9 Billion JPY | 11.87% |
| 2010 | 10.63 Billion JPY | -3.25% |
| 2009 | 10.99 Billion JPY | 16.99% |
| 2008 | 9.39 Billion JPY | -11.99% |
| 2007 | 10.68 Billion JPY | 7.32% |
| 2006 | 9.95 Billion JPY | -13.77% |
| 2005 | 11.54 Billion JPY | -6.66% |
| 2004 | 12.36 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 13.9 Billion JPY | 4.57% |
| 2024 Q2 | 13.89 Billion JPY | -0.04% |
| 2024 Q3 | 14.52 Billion JPY | 4.49% |
| 2023 Q4 | 13.29 Billion JPY | -2.13% |
| 2023 Q1 | 12.51 Billion JPY | -13.52% |
| 2023 Q3 | 13.58 Billion JPY | 4.48% |
| 2023 FY | 13.29 Billion JPY | -8.07% |
| 2023 Q2 | 13 Billion JPY | 3.96% |
| 2022 Q2 | 12.8 Billion JPY | 5.4% |
| 2022 Q4 | 14.46 Billion JPY | 26.79% |
| 2022 FY | 14.46 Billion JPY | 4.85% |
| 2022 Q1 | 12.14 Billion JPY | -11.97% |
| 2022 Q3 | 11.4 Billion JPY | -10.87% |
| 2021 Q4 | 13.79 Billion JPY | 7.24% |
| 2021 FY | 13.79 Billion JPY | 26.14% |
| 2021 Q1 | 12.45 Billion JPY | 13.92% |
| 2021 Q2 | 10.95 Billion JPY | -12.09% |
| 2021 Q3 | 12.86 Billion JPY | 17.46% |
| 2020 Q2 | 10.62 Billion JPY | -1.9% |
| 2020 Q1 | 10.82 Billion JPY | -59.62% |
| 2020 FY | 10.93 Billion JPY | -59.22% |
| 2020 Q4 | 10.93 Billion JPY | 6.61% |
| 2020 Q3 | 10.25 Billion JPY | -3.43% |
| 2019 Q4 | 26.81 Billion JPY | -22.86% |
| 2019 FY | 26.81 Billion JPY | 62.99% |
| 2019 Q2 | 35.73 Billion JPY | 6.32% |
| 2019 Q1 | 33.6 Billion JPY | 104.25% |
| 2019 Q3 | 34.76 Billion JPY | -2.71% |
| 2018 Q4 | 16.45 Billion JPY | -0.71% |
| 2018 FY | 16.45 Billion JPY | -6.64% |
| 2018 Q1 | 15.51 Billion JPY | -11.95% |
| 2018 Q2 | 15.56 Billion JPY | 0.32% |
| 2018 Q3 | 16.57 Billion JPY | 6.45% |
| 2017 Q4 | 17.62 Billion JPY | 14.91% |
| 2017 Q2 | 14.09 Billion JPY | -3.52% |
| 2017 Q1 | 14.6 Billion JPY | -2.42% |
| 2017 Q3 | 15.33 Billion JPY | 8.83% |
| 2017 FY | 17.62 Billion JPY | 17.73% |
| 2016 Q3 | 13.64 Billion JPY | -4.09% |
| 2016 FY | 14.97 Billion JPY | -6.69% |
| 2016 Q2 | 14.22 Billion JPY | -5.34% |
| 2016 Q4 | 14.97 Billion JPY | 9.75% |
| 2016 Q1 | 15.02 Billion JPY | -6.35% |
| 2015 Q2 | 12.96 Billion JPY | -6.41% |
| 2015 Q3 | 16.68 Billion JPY | 28.74% |
| 2015 Q1 | 13.84 Billion JPY | 0.0% |
| 2015 FY | 16.04 Billion JPY | 30.15% |
| 2015 Q4 | 16.04 Billion JPY | -3.85% |
| 2014 Q1 | 14.12 Billion JPY | 11.04% |
| 2014 FY | 12.32 Billion JPY | -12.7% |
| 2014 Q3 | 13.14 Billion JPY | 9.69% |
| 2014 Q2 | 11.97 Billion JPY | -15.17% |
| 2013 Q4 | 12.71 Billion JPY | 4.24% |
| 2013 Q1 | 14.65 Billion JPY | 1.82% |
| 2013 Q2 | 11.16 Billion JPY | -23.81% |
| 2013 Q3 | 12.2 Billion JPY | 9.3% |
| 2013 FY | 14.12 Billion JPY | -3.62% |
| 2012 Q3 | 13.3 Billion JPY | 37.37% |
| 2012 FY | 14.65 Billion JPY | 23.1% |
| 2012 Q4 | 14.38 Billion JPY | 8.17% |
| 2012 Q2 | 9.68 Billion JPY | -18.64% |
| 2012 Q1 | 11.9 Billion JPY | 13.4% |
| 2011 Q3 | 10.75 Billion JPY | 3.69% |
| 2011 FY | 11.9 Billion JPY | 11.87% |
| 2011 Q1 | 10.63 Billion JPY | 8.77% |
| 2011 Q2 | 10.37 Billion JPY | -2.53% |
| 2011 Q4 | 10.49 Billion JPY | -2.39% |
| 2010 Q1 | 10.99 Billion JPY | 10.05% |
| 2010 Q3 | 10.09 Billion JPY | 12.74% |
| 2010 Q4 | 9.78 Billion JPY | -3.12% |
| 2010 FY | 10.63 Billion JPY | -3.25% |
| 2010 Q2 | 8.95 Billion JPY | -18.56% |
| 2009 Q4 | 9.99 Billion JPY | 5.09% |
| 2009 FY | 10.99 Billion JPY | 16.99% |
| 2009 Q3 | 9.5 Billion JPY | 0.0% |
| 2009 Q1 | 9.39 Billion JPY | 22.96% |
| 2008 FY | 9.39 Billion JPY | -11.99% |
| 2008 Q4 | 7.64 Billion JPY | 0.0% |
| 2007 FY | 10.68 Billion JPY | 7.32% |
| 2006 FY | 9.95 Billion JPY | -13.77% |
| 2005 FY | 11.54 Billion JPY | -6.66% |
| 2004 FY | 12.36 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | 46.786% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.83% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 98.23% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 91.91% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -291.667% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 68.982% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | 52.282% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 97.313% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -163.829% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 78.447% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | 56.873% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | 66.585% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | 57.222% |
| Tsumura & Co. | 132.88 Billion JPY | 89.994% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | 66.583% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 95.16% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 69.888% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 81.194% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | 71.644% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -89.876% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | 47.73% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -63.311% |
| MedRx Co., Ltd | 129 Million JPY | -10207.752% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -306.321% |
| Solasia Pharma K.K. | 673 Million JPY | -1875.78% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -1959.944% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | 57.627% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 91.892% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -1214.79% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 97.462% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -91.259% |